Pall and New Brunswick Collaborate on Single-Use Bioreactors

July 6, 2010
BioPharm International Editors

New Brunswick Scientific, an Eppendorf Company (Edison, NJ), and Pall Corporation (Port Washington, NY) have entered into a product development and marketing agreement to create and supply new disposable bioreactor systems.

New Brunswick Scientific, an Eppendorf Company (Edison, NJ), and Pall Corporation (Port Washington, NY) have entered into a product development and marketing agreement to create and supply new disposable bioreactor systems.
The joint effort will build on the capabilities of Pall's Allegro single-use biocontainer platform and New Brunswick's CelliGen bioprocess controller to better serve upstream applications ranging from the process development laboratory to the full-scale cGMP production suite.